Statement of Principles concerning popliteal cyst (Reasonable Hypothesis) (No. 31 of 2018)

This Statement of Principles (No. 31 of 2018) sets the factual and medical thresholds that, for the purposes of veterans’ benefits law, constitute a "reasonable hypothesis" linking a diagnosis of popliteal cyst or death from popliteal cyst to relevant service. The instrument is made by the Repatriation Medical Authority under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (VEA) (s3). It commences on 2 April 2018 (s2) and applies to claims that fall within the claim-making provisions identified in the instrument: namely claims to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 (MRCA) applies (s4).

Mechanically, the instrument performs two linked functions. First, it defines the clinical meaning of "popliteal cyst" for claims purposes (s6(2) and notes). The definition is narrower than simply citing ICD codes, because although ICD‑10‑AM codes M66.0 and M71.2 are noted, the instrument explicitly says that, for application of the Statement of Principles, popliteal cyst means the swelling described in subsection 6(2) (s6(3)-(4)). Second, it lists the minimum factors that must exist to raise the statutory "reasonable hypothesis" that the condition is related to relevant service (s8). Those factors include, among others, presence of an injury or disease causing synovitis at clinical onset or clinical worsening (s8(1) and (3)), prior partial or total knee replacement (s8(2) and (4)), physical activity of at least five METS at the time of rupture (s8(5)), and inability to obtain appropriate clinical management (s8(6)).

The Statement also addresses death from popliteal cyst by including terminal events or conditions to which a popliteal cyst may have contributed (s6(5); Schedule 1). It requires that any of the listed factors be related to the person’s relevant service (s9(1)) and clarifies when certain aggravation/material contribution factors apply, namely only where the cyst was suffered or contracted before or during, but did not arise out of, relevant service (s9(2)). Finally, the instrument integrates with other Statements of Principles by directing that, where a listed factor refers to an injury or disease already covered by another Statement, the factors in that other Statement apply (s10).

In short, the instrument does not itself grant benefits or impose penalties. It prescribes the medical and factual inputs that decision makers should treat as sufficient to raise a reasonable hypothesis linking popliteal cyst (or death from it) to relevant service, thereby affecting entitlement determinations under the VEA and MRCA (s3-s4, s8-s10).

The instrument defines a small set of core concepts and legal thresholds that govern its application. The principal definitional concept is popliteal cyst itself. For the instrument’s purposes, popliteal cyst is "a swelling in the popliteal fossa due to enlargement of the gastrocnemius-semimembranosus bursa, where the swelling is associated with clinical manifestations" (s6(2)). The instrument also provides clinical manifestations as examples , palpable mass behind the knee, posterior knee pain, stiffness, tightness and limited range of motion, with possible enlargement, dissection or rupture and potential compression or inflammation of adjacent structures (note under s6(2)). Although ICD‑10‑AM codes are acknowledged (M66.0 or M71.2), the instrument emphasises that its operative meaning is set out in subsection 6(2) rather than the code alone (s6(3)-(4)).

Another central concept is the statutory threshold of "reasonable hypothesis". The instrument explicitly frames section 8 as listing the minimum factors that must exist before "it can be said that a reasonable hypothesis has been raised connecting popliteal cyst or death from popliteal cyst with the circumstances of a person's relevant service" (s8). The listed factors are concrete medical or factual states or events: synovitis-causing injury/disease at clinical onset or clinical worsening (s8(1), (3)), prior partial or total knee replacement (s8(2), (4)), specified physical activity at rupture (s8(5)), and inability to obtain appropriate clinical management (s8(6)). Examples of conditions that can cause synovitis are provided by way of non-exhaustive lists that include osteoarthritis, rheumatoid arthritis, gout, meniscal tear and others (notes under s8(1) and (3)).

The instrument also defines "relevant service" in Schedule 1. Relevant service covers a range of service types under the VEA and MRCA: operational, peacekeeping, hazardous, British nuclear test defence, warlike, and non-warlike service (Schedule 1, "relevant service"). The concept of "terminal event" is defined in Schedule 1 and includes concrete proximate causes of death such as pneumonia, respiratory failure, cardiac arrest and cessation of brain function; the definition is used for cases of death that are "contributed to by the person's popliteal cyst" (s6(5) and Schedule 1).

Operationally significant cross-references are twofold. First, subsection 9(2) restricts the application of certain aggravation/material contribution factors (s8(3)-(6)) to cases where the claimant’s cyst pre-existed service or was suffered during service but did not arise out of service. Second, section 10 requires that if a factor in this Statement refers to an injury or disease already covered by another Statement of Principles determined under s196B(2) of the VEA, the factors in that other Statement apply "in accordance with the terms of that Statement" (s10). This establishes an explicit mechanism for multi-factor or multi-condition causation assessments to defer to other Statements.

This instrument affects claimants and decision makers involved in assessments of entitlement under the VEA and MRCA where popliteal cyst or death from popliteal cyst is claimed to be connected to relevant service. By its terms it applies to "a claim to which section 120A of the VEA or section 338 of the MRCA applies" (s4). That means it operates within the statutory claim framework set by those Acts, so claimants seeking service connection for popliteal cyst and the administrators and medical assessors who determine those claims will use the instrument’s factors as the minimum evidentiary predicates for a reasonable hypothesis (s8).

Who bears the evidentiary tasks: the claimant must present clinical and factual evidence that satisfies at least one of the factors listed in section 8 and show that the factor is "related to the relevant service rendered by the person" (s9(1)). Examples of claimant-side evidentiary needs implied by the instrument include demonstrating synovitis-causing injury or disease at onset or worsening (s8(1), (3)), establishing prior knee replacement timing (s8(2), (4)), documenting intensity of activity at the time of rupture (s8(5)), and producing evidence of inability to obtain appropriate clinical management (s8(6)). The instrument does not prescribe the form of evidence required, but it sets these as the thresholds that must exist to raise a reasonable hypothesis.

Medical practitioners and reporting clinicians are affected because the instrument anchors the clinical definition of popliteal cyst and the clinical manifestations that are relevant to claims (s6(2) and the note). Clinicians will need to diagnose and document synovitis and underlying synovitis-causing diseases (notes to s8), document knee prosthesis timing, and, for rupture cases, provide an assessment of whether the precipitating activity met or exceeded five METS (s8(5); Schedule 1).

Decision makers within the veterans’ entitlements system apply this instrument when adjudicating claims under the referenced statutory provisions (s4). The Repatriation Medical Authority made the instrument and therefore supplies the medical standard, but the instrument itself prescribes principles used in administrative adjudication rather than administratively deciding individual claims (s3, s4, s7, s8).

Other affected parties include insurers or rehabilitation providers insofar as decision outcomes under the VEA or MRCA influence entitlements, treatment referrals, or rehabilitation obligations for claimants. Where a factor nominated in this Statement refers to another injury or disease that has its own Statement of Principles, the claimant and decision maker must engage the other Statement as it applies "as in force from time to time" (s10), meaning that multiple Statements may intersect in evaluating a claim.

The instrument itself does not create statutory duties or rights in the civil penalty or criminal sense. Rather, it establishes the minimum factual and medical elements that must be present to raise a "reasonable hypothesis" of service connection for popliteal cyst or death from popliteal cyst, and thereby affects the procedural rights of claimants and the duties of decision makers assessing claims under the VEA and MRCA.

Claimants’ procedural right: a claimant has the right to have their claim assessed against the medical and factual criteria in this Statement. Practically, that means a claimant who adduces evidence satisfying at least one of the factors in section 8, and who links that factor to relevant service under section 9, will have raised the reasonable hypothesis required by the Statement (s8, s9). The scope of what a claimant must show is constrained to the listed factors; no factor outside the list is prescribed as necessary by this instrument (s8).

Duty of decision makers: decision makers evaluating claims to which the referenced statutory provisions apply must consider whether the minimum factors listed in the Statement exist and whether any such factor is related to relevant service. Although the instrument does not itself say "decision makers must", the Statement’s purpose under subsection 196B(2) is to provide the medical standard used in claim assessments. Section 9 requires that any factor in section 8 "must be related to the relevant service rendered by the person" for the reasonable hypothesis to be raised (s9(1)). For aggravation/material contribution factors listed in subsections 8(3) to 8(6), subsection 9(2) restricts their application to cases where the popliteal cyst was suffered or contracted before or during, but did not arise out of, relevant service (s9(2)).

Duty to coordinate with other Statements: if a factor in this Statement refers to another injury or disease covered by a different Statement of Principles, the factors in that other Statement apply "in accordance with the terms of that Statement as in force from time to time" (s10). This places an evidential and interpretive duty on decision makers to consult and apply relevant other Statements when the causal chain involves other defined conditions.

Medical and evidentiary duties on claimants and clinicians: the instrument imposes an evidentially framed duty on the claimant to produce clinical documentation supporting the existence of at least one section 8 factor and its relationship to service (s8, s9). Clinicians who provide medico-legal reports must document clinical manifestations listed at subsection 6(2), identify synovitis and its cause where applicable (s6(2); s8 notes), and for rupture scenarios provide an assessment of activity intensity against the 5 MET threshold (s8(5); Schedule 1). The instrument leaves the assessment of "appropriate clinical management" undefinied, so clinicians’ reporting on inability to obtain appropriate management will be relied upon by decision makers and may be scrutinised for sufficiency (s8(6)).

The Statement of Principles instrument does not create or specify criminal offences, civil penalties, fines or administrative sanctions. The instrument’s text is concerned exclusively with defining a medical standard for linking popliteal cyst or death from popliteal cyst to relevant service and with procedural application to claims under the VEA and MRCA (s3-s4, s6-s10). It grants no enforcement powers and prescribes no penalty regime.

Enforcement in practice is administrative and indirect. The primary enforcement effect of the instrument is through its role in entitlement decision-making under the VEA and MRCA. That is, the Statement shapes adjudicative outcomes by specifying the factors that, if present and related to relevant service, will raise a reasonable hypothesis of service connection (s8-s9). Decision makers charged with determining claims under the referenced statutory provisions will apply the Statement as part of their medical-causation analysis. If a decision maker finds that a claimant has not met the factors in section 8, the claimant’s application for service connection may be refused, or the claimed condition may not be accepted as service-related. Those administrative outcomes are the instrument’s practical enforcement mechanism.

The instrument contains no internal review mechanism or appellate pathway; appeals and reviews would be governed by the procedures and rights in the VEA, MRCA and associated administrative law, which are not set out in this Statement (s4). Similarly, the Statement does not purport to direct disciplinary or professional action against clinicians; it is a medical standard for claims assessment and does not create clinical regulatory obligations.

Discretion and uncertainty in application may invite contestation. Because the Statement leaves certain terms open to interpretation, such as "appropriate clinical management" (s8(6)), or how to measure and document five METS of activity at the time of rupture (s8(5); Schedule 1), decision makers will exercise judgment in assessing evidence. Such judgments can be subject to administrative review or judicial review under the general legal framework applicable to decisions made under the primary Acts, though those procedural routes are beyond the instrument’s text. The instrument’s own text contains no enforcement provisions, penalties or instructions regarding administrative review.

The instrument is made under subsection 196B(2) of the VEA and is explicitly applied to claims falling under section 120A of the VEA and section 338 of the MRCA (s3-s4). The instrument therefore functions as a standards-setting medical instrument within the statutory claim framework of those Acts. It is not standalone legislation; rather, it is a subordinate instrument that informs how the primary Acts’ claim provisions are to be interpreted medically and factually for popliteal cyst.

Cross-Statement interaction: the instrument explicitly provides that where a factor in this Statement refers to an injury or disease that is the subject of another Statement of Principles determined under subsection 196B(2) of the VEA, the provisions of that other Statement apply as in force from time to time (s10). This is an instruction to harmonise and defer to other Statements when causation involves conditions already regulated by separate Statements. Practically, this means that if a popliteal cyst factor invokes, for example, osteoarthritis or a meniscal tear that itself is covered by another Statement, the analytic and factor rules of that other Statement will be incorporated into the evaluation in accordance with that Statement’s terms (s8 notes; s10).

ICD coding and diagnostic systems: the instrument notes relevant ICD‑10‑AM codes (M66.0, M71.2) but makes clear that the operative legal meaning is the instrument’s own clinical definition (s6(3)-(4)). The instrument therefore uses medical classification systems for reference while reserving its own textual definition as determinative. The ICD‑10‑AM reference is tied to the 2017 Tenth Edition effective 1 July 2017 and copyrighted by the Independent Hospital Pricing Authority (s6(4)). Where practitioners or decision makers rely on standard coding in clinical records, they must nonetheless match the clinical presentation to the instrument’s definition.

Interaction with VEA/MRCA causation and claims rules: while the Statement specifies factors that raise a reasonable hypothesis, the ultimate legal effect,acceptance of service connection, award of entitlements, and any review or appeal rights,remains governed by the VEA and MRCA claim-processing provisions referenced in section 4. The Statement does not itself alter the statutory standards of entitlement or review; it supplies the medical-causation input used in applying those statutory provisions. Section 9 imposes a requirement that the factors be "related to the relevant service rendered by the person", thereby tying the medical factors back into the statutory concept of relevant service as defined in Schedule 1.

The instrument carries a single date of making and a commencement date. It is the Statement of Principles concerning popliteal cyst (Reasonable Hypothesis) (No. 31 of 2018), dated 2 March 2018 (cover) and it commenced on 2 April 2018 (s1-s2). The instrument displays the Common Seal of the Repatriation Medical Authority and is signed by the Chairperson, Professor Nicholas Saunders AO (cover). There are no amendment clauses within the instrument itself and no later amendment history is contained in the text you provided.

Because the instrument explicitly refers to other Statements of Principles "as in force from time to time" (s10), it is constructed to operate alongside future or previous Statements without requiring amendment for every interplay. The instrument also references a specific edition of the ICD‑10‑AM (Tenth Edition, effective date 1 July 2017) for code references (s6(4)). If a later edition of ICD‑10‑AM were to be relied on administratively, that would be a policy or administrative change rather than an amendment to this instrument unless the Repatriation Medical Authority expressly updated the instrument.

Absent any other documents in the source text, there is no recorded subsequent amendment, revocation or replacement in the instrument you provided. The document itself is the making instrument dated 2 March 2018 and commencing 2 April 2018 (cover; s2). Any later amendment or repeal would need to be recorded in a separate legislative instrument or notice by the Repatriation Medical Authority, but that information is not included in the supplied text.

The supplied instrument contains no references to judicial decisions, litigation, contested administrative outcomes, or examples of case law that interpret or apply this particular Statement of Principles. It names no cases. It does not record any challenges to the instrument’s validity, content, or application.

Because the instrument is procedural and medical in nature , setting the minimum factors that raise a reasonable hypothesis for causation , disputes about its application could arise in administrative review or judicial proceedings concerning claims under the VEA and MRCA. However, no such litigation history is contained in the text you provided. The instrument itself does not cite precedent or describe any past adjudications that informed its drafting. Section 7 simply states that the Repatriation Medical Authority is "of the view that there is sound medical‑scientific evidence" supporting a relationship between popliteal cyst and relevant service; it does not identify particular studies or judgments (s7).

If a practitioner needs to know whether courts or tribunals have considered this Statement, or how it has been applied in disputes, those records must be sought outside the instrument in administrative decisions, tribunal determinations, or court reports because the instrument contains no litigation history.

The instrument is concise, but there are specific technical and evidentiary pitfalls that will be relevant to claimants, clinicians and decision makers. First, the instrument defines popliteal cyst narrowly: it must be a swelling in the popliteal fossa due to enlargement of the gastrocnemius-semimembranosus bursa with associated clinical manifestations (s6(2)). The text warns that clinical manifestations include a small set of signs and symptoms, and also notes possible enlargement, dissection or rupture. Practitioners should not assume that an ICD code alone proves the relevant legal definition; the instrument explicitly states that "in applying this Statement of Principles the meaning of popliteal cyst is that given in subsection (2)" and not merely the ICD code citation (s6(3)). That creates a potential evidentiary mismatch where clinical records record an ICD code without accompanying narrative tying the clinical presentation to the instrument’s wording.

Second, the instrument requires at least one of the enumerated factors in section 8. Some are time-sensitive: s8(1) and s8(2) require injuries/diseases or knee replacement "before the clinical onset" of the popliteal cyst; s8(3) and s8(4) require these states "at the time of the clinical worsening" of the cyst. The instrument therefore distinguishes onset from worsening and links evidentiary relevance to timing. If clinical notes are imprecise about timing or do not explicitly establish whether synovitis-causing disease was present at onset or at clinical worsening, the claim may fail to meet the minimum factor requirement.

Third, subsections 8(3) to 8(6) have a constrained application under subsection 9(2): they "apply only to material contribution to, or aggravation of, popliteal cyst where the person's popliteal cyst was suffered or contracted before or during (but did not arise out of) the person's relevant service" (s9(2)). That means if the cyst arose out of service then these aggravation/material contribution clause factors either do not operate in the way they would for pre-existing conditions, or their evidentiary role is limited. Practitioners must pay attention to whether the cyst arose out of service or was a pre-existing condition that was aggravated by service events.

Fourth, the MET threshold for rupture is precise: undertaking physical activity at a minimum intensity of five METS is required at the time of clinical worsening manifesting as rupture (s8(5); Schedule 1). MET is defined numerically in the Schedule (1 MET = 3.5 ml O2/kg/min, 1.0 kcal/kg/hr, resting metabolic rate). Translating an activity described in lay terms into a MET value requires either clinical estimation or reference to accepted MET compendia. The instrument does not provide guidance on how to measure or document METS in a robust way for claims, so evidentiary disputes can arise where activity intensity is asserted but not objectively measured.

For claimants and practitioners preparing or assessing a claim involving popliteal cyst or death from popliteal cyst, compliance with this Statement of Principles means ensuring that the record establishes at least one of the section 8 factors and that the factor is related to the person’s relevant service (s8-s9). The following practical checklist aligns with the instrument’s text.

1. Establish the clinical diagnosis in the terms of subsection 6(2).

   • Ensure clinical documentation describes a swelling in the popliteal fossa due to enlargement of the gastrocnemius-semimembranosus bursa and records the clinical manifestations listed in the instrument: palpable posterior knee mass, posterior knee pain, stiffness, tightness in the popliteal region, and limitation of range of motion (s6(2) and the note).
   • If only an ICD code is recorded, obtain narrative clinical evidence mapping the presentation to the instrument’s definition, because the instrument states the operative meaning is subsection 6(2) rather than ICD coding alone (s6(3)-(4)).

2. Match the claim to at least one of the section 8 factors with time and causation evidence.

   • For s8(1) and s8(3): document clinical evidence that a specified injury or disease known to cause synovitis was present at the time of clinical onset (s8(1)) or at the time of clinical worsening (s8(3)). The instrument lists example causes in the notes (meniscal tear, osteoarthritis, gout, rheumatoid arthritis and others); provide clinical tests, imaging, operative notes or specialist reports that establish diagnosis and timing.
   • For s8(2) and s8(4): document dates and medical records showing partial or total knee replacement occurred before clinical onset or before clinical worsening respectively.
   • For s8(5): where rupture is alleged, obtain clinician assessment indicating the activity at the time of rupture and evidence (for example, contemporaneous reports, training logs or witness statements) that the activity met or exceeded five METS. Use a recognised MET compendium or clinical assessment to substantiate the MET level because the Schedule defines MET numerically.
   • For s8(6): document attempts to obtain clinical management and contemporaneous records showing inability to obtain appropriate care. Explain what was sought, where, and why it was not available; collect correspondence, referral rejections, waiting-list data or treating practitioner notes explaining access barriers.